help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsigos, C.
Right arrow Articles by Chrousos, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsigos, C.
Right arrow Articles by Chrousos, G. P.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 12 4167-4170
Copyright © 1997 by The Endocrine Society

Original Studies

Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation

Constantine Tsigos, Dimitris A. Papanicolaou, Ioannis Kyrou, Ruby Defensor, Constantine S. Mitsiadis and George P. Chrousos

Developmental Endocrinology Branch (C.T., D.A.P., R.D., C.S.M., G.P.C.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and Hellenic National Center for Research, Prevention and Treatment of Diabetes Mellitus and its Complications (C.T., I.K.), Athens 106 75, Greece

Address all correspondence and requests for reprints to: Constantine Tsigos, M.D., Ph.D., Hellenic National Diabetes Center, 3 Ploutarchou Street, 106 75 Athens, Greece.

Inflammatory cytokines have metabolic actions that probably contribute to the general adaptation of the organism during infectious or inflammatory stress. To examine the effects of interleukin 6 (IL-6), the main circulating cytokine, on glucose metabolism in man, we performed dose-response studies of recombinant human IL-6 in normal volunteers. Increasing single doses of IL-6 (0.1, 0.3, 1.0, 3.0, and 10.0 mg/Kg BW) were injected sc in 15 healthy male volunteers (3 in each dose) after a 12-h fast. All IL-6 doses were tolerated well and produced no significant adverse effects. We measured the circulating levels of glucose, insulin, C-peptide, and glucagon at baseline and half-hourly over 4 h after the IL-6 injection. Mean peak plasma levels of IL-6 were achieved between 120 and 240 min and were 8, 22, 65, 290, and 4050 pg/mL, respectively, for the 5 doses. After administration of the 2 smaller IL-6 doses, we observed no significant changes in plasma glucose levels, which, because of continued fasting, decreased slightly over time. By 60 min after the 3 higher IL-6 doses, however, the decline in fasting blood glucose was arrested, and glucose levels increased in a dose-dependent fashion. The concurrent levels of plasma insulin and C-peptide were not affected by any IL-6 dose. In contrast, IL-6 caused significant increases in plasma glucagon levels, which peaked between 120 and 150 min after the IL-6 injection. In conclusion, sc IL-6 administration induced dose-dependent increases in fasting blood glucose, probably by stimulating glucagon release and other counteregulatory hormones and/or by inducing peripheral resistance to insulin action.




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
M. Liesa, M. Palacin, and A. Zorzano
Mitochondrial Dynamics in Mammalian Health and Disease
Physiol Rev, July 1, 2009; 89(3): 799 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
G. R. Hajer, T. W. van Haeften, and F. L.J. Visseren
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Eur. Heart J., December 2, 2008; 29(24): 2959 - 2971.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Dotson, R. Freeman, H. J. Failing, and G. K. Adler
Hypoglycemia Increases Serum Interleukin-6 Levels in Healthy Men and Women
Diabetes Care, June 1, 2008; 31(6): 1222 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-H. Kim, J. E. Kim, H.-Y. Liu, W. Cao, and J. Chen
Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway
J. Biol. Chem., January 11, 2008; 283(2): 708 - 715.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Cree and R. R. Wolfe
Postburn trauma insulin resistance and fat metabolism
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E1 - E9.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Simon, A.-M. Prieur, P. Quartier, J. Charles Ruiz, and P. Czernichow
Early Recombinant Human Growth Hormone Treatment in Glucocorticoid-Treated Children with Juvenile Idiopathic Arthritis: A 3-Year Randomized Study
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2567 - 2573.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Fontana, J. C. Eagon, M. E. Trujillo, P. E. Scherer, and S. Klein
Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans
Diabetes, April 1, 2007; 56(4): 1010 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. G. Park, Y. S. Kang, J. Y. Kim, C. S. Lee, Y. G. Ko, W. J. Lee, K.-U. Lee, Y. I. Yeom, and S. Kim
Hormonal activity of AIMP1/p43 for glucose homeostasis
PNAS, October 3, 2006; 103(40): 14913 - 14918.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
I. Wernstedt, A. Edgley, A. Berndtsson, J. Faldt, G. Bergstrom, V. Wallenius, and J.-O. Jansson
Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R551 - R557.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
N. de Rekeneire, R. Peila, J. Ding, L. H. Colbert, M. Visser, R. I. Shorr, S. B. Kritchevsky, L. H. Kuller, E. S. Strotmeyer, A. V. Schwartz, et al.
Diabetes, Hyperglycemia, and Inflammation in Older Individuals: The Health, Aging and Body Composition study
Diabetes Care, August 1, 2006; 29(8): 1902 - 1908.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Natali, E. Toschi, S. Baldeweg, D. Ciociaro, S. Favilla, L. Sacca, and E. Ferrannini
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.
Diabetes, April 1, 2006; 55(4): 1133 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Weigert, A. M. Hennige, R. Lehmann, K. Brodbeck, F. Baumgartner, M. Schauble, H. U. Haring, and E. D. Schleicher
Direct Cross-talk of Interleukin-6 and Insulin Signal Transduction via Insulin Receptor Substrate-1 in Skeletal Muscle Cells
J. Biol. Chem., March 17, 2006; 281(11): 7060 - 7067.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
O. P. Kristiansen and T. Mandrup-Poulsen
Interleukin-6 and Diabetes: The Good, the Bad, or the Indifferent?
Diabetes, December 1, 2005; 54(suppl_2): S114 - S124.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Kralisch, J. Klein, U. Lossner, M. Bluher, R. Paschke, M. Stumvoll, and M. Fasshauer
Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E586 - E590.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Bach, D. Naon, S. Pich, F. X. Soriano, N. Vega, J. Rieusset, M. Laville, C. Guillet, Y. Boirie, H. Wallberg-Henriksson, et al.
Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle: Effects of Type 2 Diabetes, Obesity, Weight Loss, and the Regulatory Role of Tumor Necrosis Factor {alpha} and Interleukin-6
Diabetes, September 1, 2005; 54(9): 2685 - 2693.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Weigert, A. M. Hennige, K. Brodbeck, H. U. Haring, and E. D. Schleicher
Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt
Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E251 - E257.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Margeli, K. Skenderi, M. Tsironi, E. Hantzi, A.-L. Matalas, C. Vrettou, E. Kanavakis, G. Chrousos, and I. Papassotiriou
Dramatic Elevations of Interleukin-6 and Acute-Phase Reactants in Athletes Participating in the Ultradistance Foot Race Spartathlon: Severe Systemic Inflammation and Lipid and Lipoprotein Changes in Protracted Exercise
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3914 - 3918.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
L. Rosendal, K. Sogaard, M. Kjaer, G. Sjogaard, H. Langberg, and J. Kristiansen
Increase in interstitial interleukin-6 of human skeletal muscle with repetitive low-force exercise
J Appl Physiol, February 1, 2005; 98(2): 477 - 481.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Fasshauer, J. Klein, S. Kralisch, M. Klier, U. Lossner, M. Bluher, and R. Paschke
Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes
J. Endocrinol., December 1, 2004; 183(3): 561 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. B. Di Gregorio, L. Hensley, T. Lu, G. Ranganathan, and P. A. Kern
Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E182 - E187.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. A. Febbraio, N. Hiscock, M. Sacchetti, C. P. Fischer, and B. K. Pedersen
Interleukin-6 Is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction
Diabetes, July 1, 2004; 53(7): 1643 - 1648.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Weigert, K. Brodbeck, H. Staiger, C. Kausch, F. Machicao, H. U. Haring, and E. D. Schleicher
Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-{kappa}B
J. Biol. Chem., June 4, 2004; 279(23): 23942 - 23952.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Faldt, I. Wernstedt, S. M. Fitzgerald, K. Wallenius, G. Bergstrom, and J.-O. Jansson
Reduced Exercise Endurance in Interleukin-6-Deficient Mice
Endocrinology, June 1, 2004; 145(6): 2680 - 2686.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. G. Pittas, N. A. Joseph, and A. S. Greenberg
Adipocytokines and Insulin Resistance
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 447 - 452.
[Full Text] [PDF]

Home page
 DiabetesHome page
P. J. Klover, T. A. Zimmers, L. G. Koniaris, and R. A. Mooney
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Diabetes, November 1, 2003; 52(11): 2784 - 2789.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Stenlof, I. Wernstedt, T. Fjallman, V. Wallenius, K. Wallenius, and J.-O. Jansson
Interleukin-6 Levels in the Central Nervous System Are Negatively Correlated with Fat Mass in Overweight/Obese Subjects
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4379 - 4383.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Febbraio, P. Ott, H. B. Nielsen, A. Steensberg, C. Keller, P. Krustrup, N. H. Secher, and B. K. Pedersen
Hepatosplanchnic clearance of interleukin-6 in humans during exercise
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E397 - E402.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. Steensberg, C. P Fischer, M. Sacchetti, C. Keller, T. Osada, P. Schjerling, G. van Hall, M. A Febbraio, and B. K. Pedersen
Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans
J. Physiol., April 15, 2003; 548(2): 631 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Chia, M. Qadan, R. Newton, C. A. Ludlam, K. A.A. Fox, and D. E. Newby
Intra-Arterial Tumor Necrosis Factor-{alpha} Impairs Endothelium-Dependent Vasodilatation and Stimulates Local Tissue Plasminogen Activator Release in Humans
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 695 - 701.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. W Helge, B. Stallknecht, B. K. Pedersen, H. Galbo, B. Kiens, and E. A Richter
The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle
J. Physiol., January 1, 2003; 546(1): 299 - 305.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney
Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes
Diabetes, December 1, 2002; 51(12): 3391 - 3399.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, and D. Giugliano
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Circulation, October 15, 2002; 106(16): 2067 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. A. FEBBRAIO and B. K. PEDERSEN
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles
FASEB J, September 1, 2002; 16(11): 1335 - 1347.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A.D. Pradhan and P.M. Ridker
Do atherosclerosis and type 2 diabetes share a common inflammatory basis?
Eur. Heart J., June 1, 2002; 23(11): 831 - 834.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
O. Ronsen, T. Lea, R. Bahr, and B. K. Pedersen
Enhanced plasma IL-6 and IL-1ra responses to repeated vs. single bouts of prolonged cycling in elite athletes
J Appl Physiol, June 1, 2002; 92(6): 2547 - 2553.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
I. Kosmidou, T. Vassilakopoulos, A. Xagorari, S. Zakynthinos, A. Papapetropoulos, and C. Roussos
Production of Interleukin-6 by Skeletal Myotubes . Role of Reactive Oxygen Species
Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 587 - 593.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Mohamed-Ali, L. Flower, J. Sethi, G. Hotamisligil, R. Gray, S. E. Humphries, D. A. York, and J. Pinkney
{beta}-Adrenergic Regulation of IL-6 Release from Adipose Tissue: In Vivo and in Vitro Studies
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5864 - 5869.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. Steensberg, M. A Febbraio, T. Osada, P. Schjerling, G. van Hall, B. Saltin, and B. K. Pedersen
Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content
J. Physiol., December 1, 2001; 537(2): 633 - 639.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
B. K. Pedersen, A. Steensberg, and P. Schjerling
Muscle-derived interleukin-6: possible biological effects
J. Physiol., October 15, 2001; 536(2): 329 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. Steensberg, A. D. Toft, P. Schjerling, J. Halkjar-Kristensen, and B. K. Pedersen
Plasma interleukin-6 during strenuous exercise: role of epinephrine
Am J Physiol Cell Physiol, September 1, 2001; 281(3): C1001 - C1004.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
JAMA, July 18, 2001; 286(3): 327 - 334.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
R L Starkie, M J Arkinstall, I Koukoulas, J A Hawley, and M A Febbraio
Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans
J. Physiol., June 1, 2001; 533(2): 585 - 591.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, M. Vayreda, C. Richart, C. Gutierrez, M. Broch, J. Vendrell, and W. Ricart
Circulating Interleukin 6 Levels, Blood Pressure, and Insulin Sensitivity in Apparently Healthy Men and Women
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1154 - 1159.
[Abstract] [Full Text]

Home page
 J. Physiol.Home page
A. Steensberg, G. van Hall, T. Osada, M. Sacchetti, B. Saltin, and B. K. Pedersen
Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6
J. Physiol., November 15, 2000; 529(1): 237 - 242.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J.-P. Bastard, C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, H. Vidal, and B. Hainque
Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3338 - 3342.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. Inui
Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key?
Cancer Res., September 1, 1999; 59(18): 4493 - 4501.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Tsigos, I. Kyrou, G. P. Chrousos, and D. A. Papanicolaou
Prolonged Suppression of Corticosteroid-Binding Globulin by Recombinant Human Interleukin-6 in Man
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3379 - 3379.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society